Phenytoin Sodium, Extended Release Interactions
There are 855 drugs known to interact with Phenytoin Sodium, Extended Release (phenytoin), along with 12 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 243 are major, 566 are moderate, and 46 are minor.
- View all 855 medications that may interact with Phenytoin Sodium, Extended Release
- View Phenytoin Sodium, Extended Release alcohol/food interactions (1)
- View Phenytoin Sodium, Extended Release disease interactions (12)
Most frequently checked interactions
View interaction reports for Phenytoin Sodium, Extended Release (phenytoin) and the medicines listed below.
- acetaminophen
- alprazolam
- amlodipine
- aspirin
- atorvastatin
- baclofen
- citalopram
- clonazepam
- clopidogrel
- cyclobenzaprine
- furosemide
- gabapentin
- hydroxyzine
- ibuprofen
- lamotrigine
- levetiracetam
- levothyroxine
- lisinopril
- loratadine
- lorazepam
- losartan
- metformin
- omeprazole
- pantoprazole
- potassium chloride
- simvastatin
- topiramate
- trazodone
- Vitamin D3 (cholecalciferol)
- warfarin
Phenytoin Sodium, Extended Release alcohol/food interactions
There is 1 alcohol/food interaction with Phenytoin Sodium, Extended Release (phenytoin).
Phenytoin Sodium, Extended Release disease interactions
There are 12 disease interactions with Phenytoin Sodium, Extended Release (phenytoin) which include:
- blood dyscrasias
- liver disease
- porphyria
- renal dysfunction
- cardiotoxicity
- suicidal tendency
- arrhythmias
- hyperglycemia
- megaloblastic anemia
- osteomalacia
- alcoholism
- thyroid function tests
Report options
More about Phenytoin Sodium, Extended Release (phenytoin)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: hydantoin anticonvulsants
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.